You are here

Relmada Therapeutics

Relmada reports DMC assessment indicates Phase 3 Reliance II trial is futile

Yahoo Finance

Thu, 12/5/24 - 11:30 am

Relmada Therapeutics

clinical trials

major depressive disorder

Promise for Relmada Therapeutics’s antidepressant REL-1017, but more data required

Clinical Trials Arena

Mon, 09/25/23 - 10:07 am

Relmada Therapeutics

clinical trials

antidepressants

Relmada Looks to Rebound with New Protocol After Two Phase III Flops

BioSpace

Mon, 03/27/23 - 10:05 am

Relmada Therapeutics

major depressive disorder

Relmada, reeling from 2 late-phase flops, plots comeback for depression drug

Fierce Biotech

Fri, 03/24/23 - 10:02 am

Relmada Therapeutics

clinical trials